Refining CAR-NK Design - Top-Institutions - MDSpire

Refining CAR-NK Design

Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.

  • March 4, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cellular Immunotherapy
    • Hematologic Malignancies
    • Immuno-oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Cellular Therapy
    • Hematology
    • Immunotherapy

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Cell Therapy
    • Immunology
    • Hematologic Malignancies

  • #4

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Immunotherapy
    • Cellular Therapy
    • Translational Research

Original Source(s)

Refining CAR-NK Design

  • March 4, 2026

Related Content

Epstein-Barr virus associated diseases: Immune alterations and targeted approaches

Delays in Hematology Consultations and Non-Hematology Referrals in Blood Cancer Diagnosis: Insights from a Comprehensive National Survey in Australia

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells